External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ACCP 2026

We will be contributing to topics related to
-
09:00 PM
Duration 120mins Maryland, USA
Population Pharmacokinetics and Exposure-Response Analysis for Atezolizumab and Lurbinectedin as a Combination Maintenance Therapy for ES-SCLC
Xin Miao, Laura Perez Ramos, Eduardo Asin-Prieto, Mathilde Marchand, Phyllis Chan, Benjamin Wu, Salvador Fudio Munoz, Joanne Ma, Honghui Zhou, Suzette Girgis, Pablo Zubiaur, Joseph Chen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon